RESTON, Va., Jan. 4, 2007 (PRIME NEWSWIRE) -- TenthGate Incorporated (www.tenthgate.biz) today announced the engagement of Adjuvant, Inc. of Centerville, Virginia to provide transaction advisory services in support of the Company's mission as a medical technology holding company.
"TenthGate will utilize the Adjuvant BIOdB database of global licensing opportunities to drive opportunity identification in their search for licensing opportunities," said Adjuvant CEO Jeff Conroy. "In addition, we will provide transaction advisory services to complement and accelerate TenthGate's strategic imperatives," continued Conroy.
"We see this relationship as a value accelerator for TenthGate and our shareholders," said Tim Novak, CEO of TenthGate. "Our medical holding company business approach enhanced by Adjuvant's broad transaction experience and global insight will enable us to stream-line our technology identification and assessment," said Novak.
TenthGate Incorporated is a fully reporting holding company incorporated in Delaware which is focused on the acquisition and development of life changing, health related technologies. The range of acquired technologies will include biotech/life sciences, diagnostic and unique medical devices. Formed in 2003, the Company has acquired five intellectual properties to date, two of which have obtained FDA approval. It has identified several additional technologies for acquisition.
Adjuvant, Inc. is a strategic transaction advisory firm focused on the life science market. The Adjuvant BIOdB (www.biodb.com) is our global database of licensing priorities of over 2,500 biotechnology and pharmaceutical companies.
The TenthGate Incorporated logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3179
STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT
Except for the historical information contained herein, the matters discussed in this press release may include forward-looking statements or information. All statements, other than statements of historical fact, including, without limitation, those with respect to the objectives, plans and strategies of TenthGate Incorporated set forth herein and those preceded by or that include the words "believes," "expects," "given," "targets," "intends," "anticipates," "plans," "projects," "forecasts" or similar expressions, are forward-looking statements. Although the Company's management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward-looking statements involve a number of risks and uncertainties which could cause the Company's future results to differ materially from those anticipated. Other risks are detailed from time to time in the Company's Annual and Quarterly Reports and in its other Securities and Exchange Commission reports and statements. The Company assumes no obligation to update any of the information contained or referenced in this press release.